-transparent.png){kind=logo}
Serum level of macrophage migration inhibitory factor in Helicobacter pylori-infected patients. 2007
Tatsuya Ohkawara, and
Jun Nishihira, and
Mototsugu Kato, and
Hiroshi Takeda, and
Toshiro Sugiyama, and
Masahiro Asaka
Department of Medical Information, Hokkaido Information University, Ebetsu. tatsuya-ohkawara@umin.ac.jp
Related Publications
Tatsuya Ohkawara, and
Jun Nishihira, and
Mototsugu Kato, and
Hiroshi Takeda, and
Toshiro Sugiyama, and
Masahiro Asaka
April 2009,
The American journal of pathology,
Tatsuya Ohkawara, and
Jun Nishihira, and
Mototsugu Kato, and
Hiroshi Takeda, and
Toshiro Sugiyama, and
Masahiro Asaka
January 2019,
PloS one,
Tatsuya Ohkawara, and
Jun Nishihira, and
Mototsugu Kato, and
Hiroshi Takeda, and
Toshiro Sugiyama, and
Masahiro Asaka
April 2005,
World journal of gastroenterology,
Tatsuya Ohkawara, and
Jun Nishihira, and
Mototsugu Kato, and
Hiroshi Takeda, and
Toshiro Sugiyama, and
Masahiro Asaka
October 2015,
Genetics and molecular research : GMR,
Tatsuya Ohkawara, and
Jun Nishihira, and
Mototsugu Kato, and
Hiroshi Takeda, and
Toshiro Sugiyama, and
Masahiro Asaka
March 2019,
Cytokine,
Tatsuya Ohkawara, and
Jun Nishihira, and
Mototsugu Kato, and
Hiroshi Takeda, and
Toshiro Sugiyama, and
Masahiro Asaka
August 2006,
Helicobacter,
Tatsuya Ohkawara, and
Jun Nishihira, and
Mototsugu Kato, and
Hiroshi Takeda, and
Toshiro Sugiyama, and
Masahiro Asaka
March 2004,
Critical care medicine,
Tatsuya Ohkawara, and
Jun Nishihira, and
Mototsugu Kato, and
Hiroshi Takeda, and
Toshiro Sugiyama, and
Masahiro Asaka
January 2002,
Critical care medicine,
Tatsuya Ohkawara, and
Jun Nishihira, and
Mototsugu Kato, and
Hiroshi Takeda, and
Toshiro Sugiyama, and
Masahiro Asaka
April 2003,
Expert opinion on therapeutic targets,
Tatsuya Ohkawara, and
Jun Nishihira, and
Mototsugu Kato, and
Hiroshi Takeda, and
Toshiro Sugiyama, and
Masahiro Asaka
January 2002,
Critical care medicine,
